prospectively defined

Related by string. * Prospectively : prospectively enrolled . prospectively evaluated . applies prospectively . prospectively stratified . Prospectively AM Best . applied prospectively / defi ned . Defining . Defined . definer . defining . DEFINED : THAT TERM IS DEFINED . Foul language defined . lb Carcass Basis Defined . constitutional amendment defining . defining moment * *

Related by context. Frequent words. (Click for all words.) 75 secondary efficacy endpoints 71 prespecified 70 noninferiority 69 secondary endpoint 68 subgroup analyzes 68 evaluable 67 composite endpoint 67 evaluable patients 66 placebo controlled randomized 66 active comparator 66 nab paclitaxel 66 virologic failure 66 median PFS 66 placebo controlled clinical 66 efficacy endpoints 66 neoadjuvant chemotherapy 65 neoadjuvant 65 primary efficacy endpoint 65 mg kg dose 65 Secondary endpoints 65 Secondary endpoints include 65 Secondary endpoints included 64 DMARD 64 microalbuminuria 64 RECIST criteria 64 secondary endpoints 64 primary endpoint 64 clinical endpoints 64 adjuvant therapy 63 bosentan 63 randomized Phase III 63 FOLFIRI 63 HbA1c levels 63 tumor recurrence 63 sustained virologic response 63 primary endpoints 63 free survival PFS 63 non inferiority 62 pharmacodynamic 62 serum concentrations 62 dose cohorts 62 Pharmacokinetic 62 thromboembolic events 62 histologic 62 tolerated dose MTD 62 peginterferon alfa 2b 62 primary efficacy endpoints 62 FDG PET 61 randomized #:# 61 placebo controlled trials 61 ADAS cog 61 sunitinib 61 ECOG 61 Phase 2a trial 61 cytogenetic response 61 covariates 61 Phase 2b study 61 PCa 61 substudy 61 peginterferon 61 cardiac dysfunction 61 prospective observational 61 distant metastases 61 azacitidine 61 serum phosphorus 61 liver metastases 61 metastatic renal cell carcinoma 61 nonresponders 61 Phase 1a 61 QTc 61 limiting toxicity 61 axitinib 61 blind randomized controlled 61 CA4P 61 HER2 positive metastatic breast 60 lymph node involvement 60 mg BID 60 prospective randomized controlled 60 RG# [001] 60 LVEF 60 FOLFOX 60 phase IIa 60 prognostic factors 60 genotypic 60 plus prednisone 60 vertebral fracture 60 vicriviroc 60 dacarbazine 60 Phase III randomized 60 infarct size 60 gefitinib 60 adalimumab 60 placebo controlled studies 60 GVAX 60 mcg kg 60 Phase 1b 60 annualized relapse 60 HGS ETR1 60 nilotinib 60 CD4 + cell 60 tumor shrinkage

Back to home page